🇺🇸 FDA
Patent

US 11932871

Methods of culturing t cells and uses of same

granted A61KA61K2239/57A61K40/11

Quick answer

US patent 11932871 (Methods of culturing t cells and uses of same) held by The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center
Grant date
Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2239/57, A61K40/11, A61K40/19, A61K40/24